Hierarchical Bayesian inference for HIV dynamic differential equation models incorporating multiple treatment factors

Biometrical Journal

Volumn 52, Issue 4, 2010, Pages 470-486

  Huang, Yangxin ^a   Wu, Hulin ^b   Acosta, Edward P ^c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

Bayesian nonlinear mixed effects models; Long term HIV dynamics; Longitudinal data; Time varying drug efficacy; Treatment factors

Indexed keywords

BAYESIAN NETWORKS; DISEASES; DRUG THERAPY; INFERENCE ENGINES; NONLINEAR EQUATIONS; ORDINARY DIFFERENTIAL EQUATIONS;

BAYESIAN; BAYESIAN NONLINEAR MIXED-EFFECT MODEL; DRUG EFFICACY; HIV DYNAMICS; LONG-TERM HIV DYNAMIC; LONGITUDINAL DATA; MIXED EFFECTS MODELS; NONLINEAR MIXED EFFECTS; TIME VARYING; TIME-VARYING DRUG EFFICACY; TREATMENT FACTOR;

DYNAMICS;

EID: 77956289669     PISSN: 03233847     EISSN: 15214036     Source Type: Journal    
DOI: 10.1002/bimj.200900173     Document Type: Article

References (40)

1. Acosta, E. P., Wu, H., Walawander, A., Eron, J., Pettinelli, C., Yu, S., Neath, D., Ferguson, E., Saah, A. J., Kuritzkes, D. R. and Gerber, J. G., for the Adult ACTG 5055 Protocol Team (2004). Comparison of two indinavir/ritonavir regimens in treatment-experienced HIV-infected individuals. Journal of Acquired Immune Deficiency Syndromes 37, 1358-1366.
2. Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., Bamberger, J. D., Chesney, M. A. and Moss, A. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 14, 357-366.
3. Bonhoeffer, S., Lipsitch, M. and Levin, B. R. (1997). Evaluating treatment protocols to prevent antibiotic resistance. Proceedings of the National Academy of Sciences USA 94, 12106-12111.
4. Davidian, M. and Giltinan, D. M. (1995). Nonlinear Models for Repeated Measurement Data. Chapman & Hall, London.
5. Ding, A. A. and Wu, H. (1999). Relationships between antiviral treatment effects and biphasic viral decay rates in modeling HIV dynamics. Mathematical Biosciences 160, 63-82.
6. Ding, A. A. and Wu, H. (2000). A comparison study of models and fitting procedures for biphasic viral decay rates in viral dynamic models. Biometrics 56, 16-23.
7. Ding, A. A. and Wu, H. (2001). Assessing antiviral potency of anti-HIV therapies in vivo by comparing viral decay rates in viral dynamic models. Biostatistics 2, 13-29.
8. Elerian, O., Chib, S. and Shephard, N. (2001). Likelihood inference for discretely observed nonlinear diffusions. Econometrica 69, 959-993.
9. Gamerman, D. (1997). Markov Chain Monte Carlo: Stochastic Simulation for Bayesian Inference. Chapman & Hall, London.
10. Gelfand, A. E. and Smith, A. F. M. (1990). Sampling-based approaches to calculating marginal densities. Journal of the American Statistical Association 85, 398-409.
11. Guedj, J., Thiébaut, R. and Commences, D. (2007). Maximum likelihood estimation in dynamical models of HIV. Biometrics 63, 1198-1206.
12. Han, C., Chaloner, K. and Perelson, A. S. (2002). Bayesian analysis of a population HIV dynamic model. In: Gatsonis C, Carriquiry A, Gelman A, et al. (Eds.) Case Studies in Bayesian Statistics, vol. 6. Springer, New York, 223-237.
13. Higgins, M., Davidian, M. and Giltinan, D. M. (1997). A two-step approach to measurement error in time-dependent covariates in nonlinear mixed-effects models, with application to IGF-I pharmacokinetics. Journal of the American Statistical Association 92, 436-448.
14. Huang, Y., Rosenkranz, S. L. and Wu, H. (2003). Modeling HIV dynamics and antiviral responses with consideration of time-varying drug exposures, sensitivities and adherence. Mathematical Biosciences 184, 165-186.
15. Huang, Y. and Wu, H. (2006). A Bayesian approach for estimating antiviral efficacy in HIV dynamic model. Journal of Applied Statistics 33, 155-174.
16. Ickovics, J. R. and Melisler, A. W. (1997). Adherence in AIDS clinical trial: a framework for clinical research and clinical care. Journal of Clinical Epidemiology 50, 385-391.
17. IMSL MATH/LIBRARY. (1994). FORTRAN Subroutines for Mathematical Applications. vol. 2. Visual Numerics, Inc., Houston.
18. Klenerman, P., Phillips, R. E., Rinaldo, C. R., Wahl, L. M., Ogg, G., May, R. M., McMichael, A. J. and Nowak, M. A. (1996). Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. Proceedings of the National Academy of Sciences USA 93, 15323-15328.
19. Labbé, L. and Verttoa, D. (2006). A nonlinear mixed effect dynamic model incorporating prior exposure and adherence to treatment to describe long-term therapy outcome in HIV-patients. Journal of Pharmacokinetics and Pharmacodynamics 33, 519-542.
20. Markowitz, M., Louie, M., Hurley, A., Sun, E., Mascio, M. D., Perelson, A. S. and Ho, D. D. (2003). A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo. Journal of Virology 77, 5037-5038.
21. Molla, A., Korneyeva, M., Gao, Q., Vasavanonda, S., Schipper, P. J., Mo, H. M., Markowitz, M., Chernyavskiy, T., Niu, P., Lyons, N., Hsu, A., Granneman, G. R., Ho, D. D., Boucher, C. A., Leonard, J. M., Norbeck, D. W. and Kempf, D. J. (1996). Ordered accumulation of mutations in HIV protease confers resistance to ritonavir. Nature Medicine 2, 760-766.
22. Notermans, D. W., Goudsmit, J., Danner, S. A., de Wolf, F., Perelson, A. S., Mittler, J. (1998). Rate of HIV-1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen. AIDS 12, 1483-1490.
23. Nowak, M. A., Lloyd, A. L., Vasquez, G. M., Wiltrout, T. A., Wahl, L. M., Bischofberger, N., Williams, J., Kinter, A., Fauci, A. S., Hirsch, V. M., Lifson, J. D. (1997). Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. Journal of Virology 71, 7518-7525.
24. Nowak, M. A. and May, R. M. (2000). Virus Dynamics: Mathematical Principles of Immunology and Virology. Oxford University Press, Oxford.
25. Perelson, A. S., Essunger, P., Cao, Y., Vesanen, M., Hurley, A., Saksela, K., Markowitz, M., Ho, D. D. (1997). Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387, 188-191.
26. Perelson, A. S. and Nelson, P. W. (1999). Mathematical analysis of HIV-1 dynamics in vivo. SIAM Review 41, 3-44.
27. Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M. and Ho, D. D. (1996). HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271, 1582-1586.
28. Putter, H., Heisterkamp, S. H., Lange, J. M. A. and De Wolf, F. (2002). A Bayesian approach to parameter estimation in HIV dynamical models. Statistics in Medicine 21, 2199-2214.
29. Sheiner, L. B. (1985). Modeling pharmacodynamics: parametric and nonparametric approaches. In: Rowland M et al. (Eds.) Variability in Drug Therapy: Description, Estimation, and Control. Raven Press, New York, 139-152.
30. Singer, H. (2002). Parameter estimation of nonlinear stochastic differential equations: simulated maximum likelihood vs. extended Kalman filter and Ito-Taylor Expansion. Journal of Computational and Graphic Statistics 11, 972-995.
31. Spiegelhalter, D. J., Best, N. G., Carlin, B. P., Van der Linde, A. (2002). Bayesian measures of model complexity and fit (with Discussion). Journal of the Royal Statistics Society, Series B 64, 583-639.
32. Stafford, M. A., Corey, L., Cao, Y., Daar, E. S., Ho, D. D. and Perelson, A. S. (2000). Modeling plasma virus concentration during primary HIV infection. Journal of Theoretical Biology 203, 285-301.
33. Verotta, D. (2005). Models and estimation methods for clinical HIV-1 data. Journal of Computational and Applied Mathematics 184, 275-300.
34. Wakefield, J. C. (1996). The Bayesian analysis to population pharmacokinetic models. Journal of the American Statistical Association 91, 62-75.
35. Wu, H. and Ding, A. A. (1999). Population HIV-1 dynamics in vivo: applicable models and inferential tools for virological data from AIDS clinical trials. Biometrics 55, 410-418.
36. Wu, H., Ding, A. A. and De Gruttola, V. (1998). Estimation of HIV dynamic parameters. Statistics in Medicine 17, 2463-2485.
37. Wu, H., Huang, Y., Acosta, E. P., Apar, J-G., Rosenkranz, S. L., Kuritzkes, D. R., Eron, J. J., Perelson, A. S. and Gerber, J. G. (2006). Pharmacodynamics of antiretroviral agents in HIV-1 infected patients using viral dynamic models with consideration of drug susceptibility and adherence. Journal of Pharmacokinetics and Pharmacodynamics 33, 399-419.
38. Wu, H., Lathey, J., Ruan, P., Douglas, S. D., Spector, S. A., Lindsey, J., Hughes, M. D., Rudy, B. J., Flynn, P. M. (2004). Relationship of plasma HIV-1 RNA dynamics to baseline factors and virological responses to highly active antiretroviral therapy (HAART) in adolescents infected through risk behavior. Journal of Infectious Diseases 189, 593-601.
39. Wu, L. (2002). A joint model for nonlinear mixed-effects models with censoring and covariates measured with error, with application to AIDS studies. Journal of the American Statistical association 97, 955-964.
40. Zhu, L. and Carlin, B. P. (2000). Comparing hierarchical models for spatio-temporally misaligned data using the deviance information criterion. Statistics in Medicine 19, 2265-2278.